| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 119, 1159-1163, Copyright © 1986 by Endocrine Society
ARTICLES |
AJ Ziecik, PD Stanchev and JE Tilton
LH/hCG-binding sites were measured in crude membrane fractions of porcine uteri. Specific high affinity and low capacity receptors for LH/hCG were found in all (n = 17) membrane preparations of myometrium but in only 5 of 17 crude membrane fractions of endometrium of porcine uteri. There was very little competition between hCG and porcine GH (pGH), bovine TSH, pFSH, and pPRL (0.5%, 0.3%, 0.2%, and less than 0.005%, respectively). Specificity of [125I]hCG binding to other tissues was determined by incubating crude membrane preparations of heart, skeletal muscle, liver, and kidney. Numbers and affinities of available LH/hCG-binding sites were characterized in all samples of myometrium and 5 endometrium membrane preparations that were positive for LH/hCG receptors. The results indicate that the number of uterine LH-binding sites in myometrium (0.66 +/- 0.17 fmol/mg) is 10 times less than the receptor capacity in porcine corpora lutea (7.46 +/- 0.54 fmol/mg) when expressed per mg protein of crude membrane preparation. However, it is approximately 60 times less when expressed per mg DNA equivalent of initial homogenate (1.31 +/- 0.28 vs. 81.18 +/- 3.64 fmol/mg, respectively). Receptor affinities of uterine LH/hCG-binding sites remained comparable to those of corpora lutea receptors (Ka = 7.8 X 10(10) M-1). Concentrations of LH/hCG-binding sites in myometrium taken from gilts in the late follicular phase of the estrous cycle (0.13 +/- 0.06 fmol/mg protein; n = 5) were significantly less (P less than 0.05 and P less than 0.01) compared to those in myometrium from luteal phase (0.85 +/- 0.22 fmol/mg protein; n = 6) or early pregnancy (1.03 +/- 0.15 fmol/mg protein; n = 6), respectively. This is probably the first evidence demonstrating specific binding of [125I]hCG by LH receptors in female uterine tissue.
This article has been cited by other articles:
![]() |
G. Bodek, A. Kowalczyk, A. Waclawik, I. Huhtaniemi, and A. J. Ziecik Targeted Ablation of Prostate Carcinoma Cells Through LH Receptor Using Hecate-CG{beta} Conjugate: Functional Characteristic and Molecular Mechanism of Cell Death Pathway Experimental Biology and Medicine, June 1, 2005; 230(6): 421 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perrier d'Hauterive, C. Charlet-Renard, S. Berndt, M. Dubois, C. Munaut, F. Goffin, M.-T. Hagelstein, A. Noel, A. Hazout, J.-M. Foidart, et al. Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium Hum. Reprod., November 1, 2004; 19(11): 2633 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Fields and M. Shemesh Extragonadal Luteinizing Hormone Receptors in the Reproductive Tract of Domestic Animals Biol Reprod, November 1, 2004; 71(5): 1412 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Stewart Gonadotropins and the Uterus: Is There a Gonad-Independent Pathway? Reproductive Sciences, December 1, 2001; 8(6): 319 - 326. [Abstract] [PDF] |
||||
![]() |
M. Zheng, H. Shi, D. L. Segaloff, and B. J. Van Voorhis Expression and Localization of Luteinizing Hormone Receptor in the Female Mouse Reproductive Tract Biol Reprod, January 1, 2001; 64(1): 179 - 187. [Abstract] [Full Text] |
||||
![]() |
S. You, H. Kim, C.-C. Hsu, M. E. El Halawani, and D. N. Foster Three Different Turkey Luteinizing Hormone Receptor (tLH-R) Isoforms I: Characterization of Alternatively Spliced tLH-R Isoforms and Their Regulated Expression in Diverse Tissues Biol Reprod, January 1, 2000; 62(1): 108 - 116. [Abstract] [Full Text] |
||||
![]() |
D. Mizrachi and M. Shemesh Follicle-Stimulating Hormone Receptor and Its Messenger Ribonucleic Acid Are Present in the Bovine Cervix and Can Regulate Cervical Prostanoid Synthesis Biol Reprod, September 1, 1999; 61(3): 776 - 784. [Abstract] [Full Text] |
||||
![]() |
M. Shemesh, M. Gurevich, D. Mizrachi, L. Dombrovski, Y. Stram, M. J. Fields, and L. S. Shore Expression of Functional Luteinizing Hormone (LH) Receptor and Its Messenger Ribonucleic Acid in Bovine Uterine Veins: LH Induction of Cyclooxygenase and Augmentation of Prostaglandin Production in Bovine Uterine Veins Endocrinology, November 1, 1997; 138(11): 4844 - 4851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |